Share This Page:   

 

Browse by Clinical Topic:
Select a Topic to Learn More

Featured CME/CE Content:

 

neuroscienceCME Editors' Picks:

A Primary Care Initiative to Improve Equitable Screening and Management Strategies in NVAF

Premiere Date: Tuesday, January 31, 2023

This activity offers CE credit for:

1. ABIM (MOC)
2. Medicine (accme)
3. Nursing (ANCC)
4. Pharmacy (acpe)
5. PA (aapa)
6. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date:
Wednesday, January 31, 2024
Note: Credit Is No Longer Available

Faculty

David S. Kountz, MD, MBA, MACP (Moderator) Co-Chief Academic Officer and Vice President for Academic Diversity Hackensack Meridian Health(HMH) Professor of Medicine Senior Associate Dean for Diversity, Equity and Inclusion Hackensack Meridian School of Medicine Nutley, NJ

David J. Cho, MD, MBA  Assistant Clinical Professor Department of Cardiovascular Medicine University of California, Los Angeles David Geffen School of Medicine Co-Director, Cardiology Quality Program UCLA Health Burbank, CA

Darae Ko, MD, MSc  Assistant Scientist II Hinda and Arthur Marcus Institute for Aging Research Hebrew SeniorLife Staff Cardiologist Boston Medical Center Boston, MA

Statement of Need

Despite its prevalence, a significant number of non-valvular atrial fibrillation (NVAF) cases remain undiagnosed, putting patients at risk for cardiovascular complications, including heart failure, left ventricular dysfunction, hypertension, diabetes, stroke or embolism, and vascular disease. Primary care physicians face challenges in identifying and managing NVAF, and often fail to implement guideline-concordant care due to a lack of awareness of patients who could benefit from therapy, or lack of confidence in utilizing these therapies. In addition, patients from communities of color often do not receive the same level of care as those from other populations, while new and emerging technologies, such as smart watches, portable ECG devices, and medication/fitness trackers can both enhance patient engagement in care and create clinical quandaries for practitioners.

During this 60-minute OnDemand webcast, an interprofessional panel of experts including a cardiologist, a PCP, and a digital health specialist provide astute perspectives on how to implement equitable and contemporary NVAF screening and management strategies into clinical practice.

Learning Objectives

At the end of this CE activity, participants should be able to:

• Implement screening in primary care settings to identify patients with NVAF who might benefit from anticoagulant therapy.
• Integrate current practice guidelines into the care of patients with NVAF.
• Collaborate with team members and patients to optimize screening and management strategies for NVAF.

Financial Support

Supported by an educational grant from the Bristol Myers Squibb and Pfizer Alliance.

Target Audience

Primary care clinicians, nurse practitioners, nurses, physician assistants, pharmacists and other clinicians who help care for patients with CVD.

Credit Information

ABIM MOC:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 medical knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Learning formats:
Enduring material

Royal College MOC:
Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

MIPS Improvement Activity:
This activity counts towards MIPS Improvement Activity requirements under the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Kountz reports the following financial relationships:

Research Support: National Heart, Lung, and Blood Institute (NHLBI)

Dr. Cho has no financial relationships to disclose.

Dr. Ko reports the following financial relationships:

Consultant: Eagle Pharmaceuticals, Inc.

Research Support: Investigator initiated research from Boston Scientific Corporation

The following peer reviewer and CME Outfitters staff have no financial relationships:

Elizabeth Naber, MSN, RN, CCRN-K, CNRN, TCRN (peer reviewer)

Thomas Mitchell (planning committee)

Warren Beckman (planning committee)

John Jones, PharmD (planning committee)

Susan H. Yarbrough, CHCP (planning committee)

Sandra Caballero, PharmD (planning committee)

Sharon Tordoff (planning committee)

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).